Allstate (NYSE:ALL) PT Raised to $216.00 at UBS Group

Allstate (NYSE:ALL) had its target price lifted by research analysts at UBS Group from $215.00 to $216.00 in a report released on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the insurance provider’s stock. UBS Group’s price objective points to a potential upside of 10.41% from the company’s previous close.

A number of other brokerages also recently issued reports on ALL. Bank of America cut their price objective on Allstate from $226.00 to $216.00 and set a “buy” rating for the company in a research report on Thursday, October 10th. Evercore ISI boosted their price target on shares of Allstate from $191.00 to $195.00 and gave the company an “in-line” rating in a research note on Wednesday, October 9th. Morgan Stanley lowered their price objective on shares of Allstate from $205.00 to $200.00 and set an “overweight” rating for the company in a research report on Wednesday, July 10th. The Goldman Sachs Group boosted their target price on Allstate from $199.00 to $204.00 and gave the company a “buy” rating in a research report on Thursday, August 15th. Finally, TD Cowen raised their price target on Allstate from $193.00 to $224.00 and gave the stock a “buy” rating in a research report on Tuesday, September 3rd. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $201.06.

Allstate Stock Performance

Allstate stock opened at $195.64 on Tuesday. The firm has a 50 day simple moving average of $185.67 and a 200-day simple moving average of $173.49. The stock has a market cap of $51.63 billion, a price-to-earnings ratio of 43.19, a price-to-earnings-growth ratio of 1.74 and a beta of 0.48. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.36 and a quick ratio of 0.36. Allstate has a 1-year low of $121.70 and a 1-year high of $195.87.

Allstate (NYSE:ALL) last released its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $0.33 by $1.28. The firm had revenue of $15.71 billion for the quarter, compared to analysts’ expectations of $14.04 billion. Allstate had a return on equity of 24.05% and a net margin of 5.03%. The firm’s quarterly revenue was up 12.4% on a year-over-year basis. During the same period in the prior year, the firm posted ($4.42) earnings per share. On average, analysts expect that Allstate will post 15.19 EPS for the current year.

Insider Buying and Selling

In related news, EVP Elizabeth Brady sold 49,481 shares of the business’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the completion of the transaction, the executive vice president now owns 19,163 shares in the company, valued at approximately $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Allstate news, insider John E. Dugenske sold 36,367 shares of the stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares in the company, valued at $5,236,922.32. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Elizabeth Brady sold 49,481 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $179.09, for a total transaction of $8,861,552.29. Following the sale, the executive vice president now owns 19,163 shares of the company’s stock, valued at $3,431,901.67. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 192,530 shares of company stock worth $34,967,665 over the last 90 days. 1.80% of the stock is owned by insiders.

Institutional Investors Weigh In On Allstate

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Syon Capital LLC increased its position in Allstate by 5.4% during the fourth quarter. Syon Capital LLC now owns 2,033 shares of the insurance provider’s stock worth $285,000 after buying an additional 105 shares during the period. Fisher Asset Management LLC purchased a new stake in Allstate in the 4th quarter valued at $273,000. SageView Advisory Group LLC acquired a new stake in Allstate during the 4th quarter worth $456,000. Kapitalo Investimentos Ltda purchased a new position in Allstate during the 4th quarter worth $72,000. Finally, Los Angeles Capital Management LLC increased its stake in Allstate by 122.1% in the first quarter. Los Angeles Capital Management LLC now owns 43,640 shares of the insurance provider’s stock valued at $7,550,000 after purchasing an additional 23,990 shares during the period. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.